Efficacy and Tolerability of CIC or CDS Combined With Tolterodine In Children With neurogenic detrusor overactivity

Yan Zhang,R. Zhang,Yulin He,Jing Yang,J. Wen,Junwei Wu
2017-09-12
Abstract:A total of 44 patients with neurogenic detrusor overactivity were enrolled and randomly divided into experimental(n=24) and control(n=18) groups. The experimental group underwent CIC and CDS combined with tolterodine while the control group CIC and CDS combined with placebo. Using double-blind, placebo-controlled trial. All patients received a total of 0.1 mg/kg oral tolterodine tartrate (Detrusitol) daily or placebo, divided into two doses for 4 weeks each helped by their parents or guardians, and daily doses were individualized for each subject(The maximum dose not more than 2 mg/d). Urodynamic data and 3-day bladder diaries were obtained before and within 4 weeks of ongoing medication.
Medicine
What problem does this paper attempt to address?